ATLANTA, Jan. 11, 2007 (PRIME NEWSWIRE) -- TGC Ventures International (Pink Sheets:TGVI) announced that its head office in Hong Kong will include the recently acquired Anti-Aging Hyaluronic Acid product to its Asian marketing campaign.
Anti-Aging Hyaluronic Acid ingestible is an all-natural product that zeros-in on the body's ability to create a balanced and stable condition, and in the process can retain a healthier cell count. Hyaluronic acid is typically found in products intended for the support of connective tissues, most often in joint support and lubrication, skin moisturization and may aid in the reduction of pain and stiffness.
The Company is also considering other natural health products that would enhance market visibility in the targeted Asian markets. More than 50% of the population has used complementary or alternative medicine at least once in Europe and North America.
About TGC Ventures International Inc.:
TGC Ventures International Inc. is a medically related holding company that is targeting the burgeoning multi-trillion dollar Health Care Services and Medical Devices & Supplies Industry.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.